These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10879662

  • 21. Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'?
    Doe JY, Funk M, Mengel M, Doehring E, Ehrich JH.
    Nephrol Dial Transplant; 2006 Mar; 21(3):672-6. PubMed ID: 16326742
    [Abstract] [Full Text] [Related]

  • 22. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y, Wang F, Ding J, Zhang H, Liu X, Wang S, Xiao H, Yao Y, Liu J, Zhong X, Guan N, Su B, Wu G, Yu L.
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [Abstract] [Full Text] [Related]

  • 23. Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
    Webb NJ, Shahinfar S, Wells TG, Massaad R, Gleim GW, McCrary Sisk C, Lam C.
    Pediatr Nephrol; 2013 May; 28(5):737-43. PubMed ID: 23207876
    [Abstract] [Full Text] [Related]

  • 24. Adequate clinical control of congenital nephrotic syndrome by enalapril.
    Guez S, Giani M, Melzi ML, Antignac C, Assael BM.
    Pediatr Nephrol; 1998 Feb; 12(2):130-2. PubMed ID: 9543371
    [Abstract] [Full Text] [Related]

  • 25. [Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies].
    Boratyńska M, Mazanowska O, Szewczyk Z, Czyz W.
    Pol Tyg Lek; 1998 Feb; 47(49-50):1090-2. PubMed ID: 1305732
    [Abstract] [Full Text] [Related]

  • 26. Enalapril in children with Alport syndrome.
    Proesmans W, Van Dyck M.
    Pediatr Nephrol; 2004 Mar; 19(3):271-5. PubMed ID: 14745635
    [Abstract] [Full Text] [Related]

  • 27. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness.
    Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F.
    Am J Kidney Dis; 2002 Sep; 40(3):E9. PubMed ID: 12200826
    [Abstract] [Full Text] [Related]

  • 28. Enalapril in paediatric patients with Alport syndrome: 2 years' experience.
    Proesmans W, Knockaert H, Trouet D.
    Eur J Pediatr; 2000 Jun; 159(6):430-3. PubMed ID: 10867848
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion.
    Adler L, Mathew R, Futterweit S, Frank R, Gauthier BG, Kashtan CE, Trachtman H.
    BMC Nephrol; 2002 Feb 14; 3():2. PubMed ID: 11869456
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May 14; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 31. Resolution of proteinuria in a patient with X-linked Alport syndrome treated with cyclosporine.
    Sigmundsson TS, Palsson R, Hardarson S, Edvardsson V.
    Scand J Urol Nephrol; 2006 May 14; 40(6):522-5. PubMed ID: 17130107
    [Abstract] [Full Text] [Related]

  • 32. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP, Abbott KC, Welch PG, Yuan CM.
    Clin Nephrol; 2001 Aug 14; 56(2):89-95. PubMed ID: 11522100
    [Abstract] [Full Text] [Related]

  • 33. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D, Vats A, Moritz ML, Reitz S, Grosso MJ, Janosky JE.
    J Pediatr; 2003 Jul 14; 143(1):89-97. PubMed ID: 12915830
    [Abstract] [Full Text] [Related]

  • 34. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G.
    Am J Kidney Dis; 2000 Mar 14; 35(3):381-91. PubMed ID: 10692263
    [Abstract] [Full Text] [Related]

  • 35. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S, Chartapisak W.
    J Med Assoc Thai; 2006 Dec 14; 89(12):2145-9. PubMed ID: 17214070
    [Abstract] [Full Text] [Related]

  • 36. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb 14; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 37. [Effects of pathogenetic therapy on blood cholesterol in patients with glomerulonephritis].
    Neverov NI, Stavrovskaia EV, Kolina IB, Shvetsov MIu, Zakharova EV, Shilov EM.
    Ter Arkh; 2001 Feb 14; 73(6):37-40. PubMed ID: 11521519
    [Abstract] [Full Text] [Related]

  • 38. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021 Feb 14; 41(3):304-310. PubMed ID: 36166246
    [Abstract] [Full Text] [Related]

  • 39. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 14; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 40. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
    Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ.
    Scand J Rheumatol; 2005 Aug 14; 34(5):392-5. PubMed ID: 16234188
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.